[Therapeutic activity of a preparation based on trichopeptide].
A clinical trial of a substance containing trichopeptides in 50 patients presenting male pattern alopecia, has been made. The treatment lasted for four months. The results have shown a good response with excellent tolerance. Patch tests made on 100 control subjects have no showed any allergenic capacity of the substance.
D000287:Administration, Topical; D000328:Adult; D000505:Alopecia / Q000150:complications / Q000188:drug therapy*; D000818:Animals; D001798:Blood Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002417:Cattle; D012628:Dermatitis, Seborrheic / Q000150:complications / Q000188:drug therapy*; D004341:Drug Evaluation; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006736:Horses; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology; D012882:Skin Tests; D014020:Tissue Extracts
D001798:Blood Proteins; D011134:Polysaccharides; D014020:Tissue Extracts
Acción terapéutica de un preparado a base de tricopéptido.